AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 36 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,187,500 | -11.2% | 625,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,338,000 | -24.4% | 625,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,769,000 | -60.0% | 625,000 | -41.1% | 0.00% | -100.0% |
| Q1 2022 | $4,423,000 | -71.2% | 1,060,579 | -64.1% | 0.00% | -50.0% |
| Q4 2021 | $15,341,000 | -20.8% | 2,955,806 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $19,361,000 | -1.4% | 2,955,806 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,627,000 | +15.9% | 2,955,806 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $16,937,000 | -35.9% | 2,955,806 | 0.0% | 0.00% | -40.0% |
| Q4 2020 | $26,425,000 | -23.2% | 2,955,806 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $34,406,000 | -27.4% | 2,955,806 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $47,382,000 | +167.6% | 2,955,806 | 0.0% | 0.01% | +120.0% |
| Q1 2020 | $17,705,000 | -38.9% | 2,955,806 | +34.6% | 0.01% | -16.7% |
| Q4 2019 | $28,985,000 | +37.1% | 2,195,806 | +29.0% | 0.01% | +20.0% |
| Q3 2019 | $21,149,000 | -21.5% | 1,702,830 | +1.7% | 0.01% | -16.7% |
| Q2 2019 | $26,950,000 | +40.1% | 1,673,889 | +173.9% | 0.01% | +20.0% |
| Q1 2019 | $19,232,000 | -4.2% | 611,112 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $20,069,000 | +8.9% | 611,112 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $18,431,000 | -37.5% | 611,112 | -44.4% | 0.00% | -33.3% |
| Q2 2018 | $29,469,000 | – | 1,100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $74,286,965 | 86.51% |
| TFG Asset Management GP Ltd | 8,000,000 | $27,840,000 | 6.94% |
| STEMPOINT CAPITAL LP | 2,662,732 | $9,266,307 | 2.72% |
| Exome Asset Management LLC | 839,472 | $2,921,362 | 2.54% |
| GREAT POINT PARTNERS LLC | 3,441,667 | $11,977,001 | 2.29% |
| Affinity Asset Advisors, LLC | 4,300,000 | $14,964,000 | 1.72% |
| Deep Track Capital, LP | 15,272,172 | $53,147,159 | 1.59% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $16,089,168 | 0.75% |
| HighVista Strategies LLC | 518,820 | $1,805,494 | 0.66% |
| Avoro Capital Advisors LLC | 12,345,678 | $42,962,959 | 0.57% |